ScholarIQanswers from OpenAlex & ORCID
James N. Kochenderfer
ResearcherPublications, citations & collaboration network
James N. Kochenderfer is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James N. Kochenderfer have?
ScholarIQindexed works
James N. Kochenderfer has 247 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James N. Kochenderfer have?
ScholarIQcitation count
James N. Kochenderfer has 27,483 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James N. Kochenderfer?
ScholarIQh-index
James N. Kochenderfer has an h-index of 57 in OpenAlex.
What is the i10-index of James N. Kochenderfer?
ScholarIQi10-index
James N. Kochenderfer has an i10-index of 132 in OpenAlex.
What is the ORCID of James N. Kochenderfer?
ScholarIQorcid
The ORCID for James N. Kochenderfer is on the source record.
What is the OpenAlex record for James N. Kochenderfer?
ScholarIQopenalex
The OpenAlex for James N. Kochenderfer is on the source record.
What are the most-cited papers on James N. Kochenderfer?
ScholarIQmost cited works
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson, Yongzhi Cui, Cindy Delbrook, Steven A. Feldman, Terry J. Fry, Rimas J. Orentas, Marianna Sabatino, Nirali N. Shah, Seth M. Steinberg, D. Stroncek, Nick Tschernia, Constance M. Yuan, Hua Zhang, Ling Zhang, Steven A. Rosenberg, Alan S. Wayne, Crystal L. Mackall
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje, Jesús G. Berdeja, Yi Lin, David S. Siegel, Sundar Jagannath, Deepu Madduri, Michaela Liedtke, Jacalyn Rosenblatt, Marcela V. Maus, Ashley Turka, Lyh-Ping Lam, Richard A. Morgan, Kevin M. Friedman, Monica Massaro, Julie Wang, Greg Russotti, Zhihong Yang, Timothy Campbell, Kristen Hege, Fabio Petrocca, M. Travis Quigley, Nikhil C. Munshi, James N. Kochenderfer
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert Somerville, Robert O. Carpenter, Maryalice Stetler‐Stevenson, James C. Yang, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, Mark Raffeld, Steven A. Feldman, Lily Lu, Yong F. Li, Lien T. Ngo, André Goy, Tatyana Feldman, David Spaner, Michael Wang, Clara C. Chen, Sarah M. Kranick, Avindra Nath, Debbie-Ann N. Nathan, Kathleen E. Morton, Mary Ann Toomey, Steven A. Rosenberg
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Mark E. Dudley, Maryalice Stetler‐Stevenson, Steven A. Feldman, Irina Marić, Mark Raffeld, Debbie-Ann N. Nathan, Brock Lanier, Richard A. Morgan, Steven A. Rosenberg
B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
Robert O. Carpenter, Moses O. Evbuomwan, Stefania Pittaluga, Jeremy J. Rose, Mark Raffeld, Shicheng Yang, Ronald E. Gress, Frances T. Hakim, James N. Kochenderfer